U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Integra LifeSciences Holdings Corporation (IART)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
48.93+0.62 (+1.28%)
At close: 4:00PM EDT
People also watch
ICUIWMGIHAECNMDNUVA

Integra LifeSciences Holdings Corporation

311 Enterprise Drive
Plainsboro, NJ 08536
United States
609-275-0500
http://www.integralife.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees3,700

Key Executives

NameTitlePayExercisedAge
Mr. Peter J. ArduiniPres, CEO & Director2.29M2.18M52
Dr. Richard E. Caruso Ph.D.Founder and Chairman Emeritus75kN/A74
Mr. Glenn G. ColemanChief Financial Officer, Principal Accounting Officer and Corp. VP891.55kN/A49
Mr. Richard D. GorelickCorp. VP of Admin., Gen. Counsel and Sec.600.68kN/A56
Mr. Daniel L. ReuversCorp. VP and Pres of Specialty Surgical Solutions553.13kN/A54
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates through two segments, Specialty Surgical Solutions; and Orthopedics and Tissue Technologies. It offers neurosurgery and critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. The company also sells approximately 60,000 instrument patterns, and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. In addition, it provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, the company sells hardware products, such as bone and joint fixation, and joint replacement devices; implants; and instruments, which provide for the orthopedic reconstruction of bone in the hand, wrist, elbow, and shoulder, as well as the foot, ankle, and leg below the knee in the extremity bone and joint reconstruction procedures. It offers its products directly through various sales forces and other distribution channels in the United States, Europe, and internationally. Integra LifeSciences Holdings Corporation was founded in 1989 and is headquartered in Plainsboro, New Jersey.

Corporate Governance

Integra LifeSciences Holdings Corporation’s ISS Governance QualityScore as of September 1, 2017 is 1. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 1; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.